We documented the prevalence, distribution, and correlates of hepatitis C virus (HCV) infection among urban homeless adults.
Methods.
We sampled a community-based probability sample of 534 homeless adults from 41 shelters and meal programs in the Skid Row area of downtown Los Angeles, California. Participants were interviewed and tested for HCV, hepatitis B, and HIV. Outcomes included prevalence, distribution, and correlates of HCV infection; awareness of HCV positivity; and HCV counseling and treatment history.
Results.
Overall, 26.7% of the sample tested HCV-positive and 4.0% tested HIV-positive. In logistic regression analysis, independent predictors of HCV infection for the total sample included older age, less education, prison history, and single- and multiple-drug injection. Among lifetime drug injectors, independent predictors of HCV infection included older age, prison history, and no history of intranasal cocaine use. Among reported non-injectors, predictors of HCV infection included older age, less education, use of non-injection drugs, and three or more tattoos. Sexual behaviors and snorting or smoking drugs had no independent relationship with HCV infection. Among HCV-infected adults, nearly half (46.1%) were unaware of their infection.
Conclusions.
Despite the high prevalence of HCV infection, nearly half of the cases were hidden and few had ever received any HCV-related treatment. While injection drug use was the strongest independent predictor, patterns of injection drug use, non-injection drug use, prison stays, and multiple tattoos were also independent predictors of HCV. Findings suggest that urgent interventions are needed to screen, counsel, and treat urban homeless adults for HCV infection.
References
1.
AlterMJKruszon-MoranDNainanOVMcQuillanGMGaoFMoyerLA, The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med1999; 341:556–62.
2.
ArmstrongGLWasleyASimardEPMcQuillanGMKuhnertWLAlterMJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med2006; 144:705–14.
3.
GishRG. Treating hepatitis C: The state of the art. Gastroenterol Clin North Am2004; 33(1 Suppl 1):S1–9.
4.
ChakETalalAHShermanKESchiffERSaabS.Hepatitis C virus infection in USA: An estimate of true prevalence. Liver Int2011; 31:1090–101.
5.
Institute of Medicine. Hepatitis and liver cancer: A national strategy for prevention and control of hepatitis B and C. Washington: National Academies Press; 2010.
6.
KlinkenbergWDCaslynRJMorseGAYonkerRDMcCuddenSKetemaF, Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatry2003; 44:293–302.
7.
SchwarzKBGarrettBAlterMJThompsonDStrathdeeSA. Seroprevalence of HCV infection in homeless Baltimore families. J Health Care Poor Underserved2008; 19:580–7.
8.
CheungRCHansonAKMagantiKKeeffeEBMatsuiSM. Viral hepatitis and other infectious diseases in a homeless population. J Clin Gastroenterol2002; 34:476–80.
9.
DesaiRARosenheckRAAgnelloV.Prevalence of hepatitis C virus infection in a sample of homeless Veterans. Soc Psychiatry Psychiatr Epidemiol2003; 38:396–401.
10.
SteinJANyamathiA.Correlates of hepatitis C virus infection in homeless men: A latent variable approach. Drug Alcohol Depend2004; 75:89–95.
11.
NyamathiAMDixonELRobbinsWSmithCWileyDLeakeB, Risk factors for hepatitis C virus infection among homeless adults. J Gen Intern Med2002; 17:134–43.
12.
HallCSCharleboisEDHahnJAMossARBangsbergDR. Hepatitis C virus infection in San Francisco's HIV-infected urban poor. High prevalence but low treatment rates. J Gen Intern Med2004; 19:357–65.
13.
StrehlowAJRobertsonMJZergerSRongeyCAranguaLFarrellE, Hepatitis C among clients of health care for the homeless primary care clinics. J Health Care Poor Underserved2012. In press.
14.
GishRGAfdhalNHDieterichDTReddyKR. Management of hepatitis C virus in special populations: Patient and treatment considerations. Clin Gastroenterol Hepatol2005; 3:311–8.
15.
McKinney-Vento Homeless Assistance Act. Public Law 100-77 (1987).
16.
ManlyJJBell-McGintySTangMXSchupfNSternYMayeuxR.Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol2005; 62:1739–46.
17.
KoegelPBurnamMAFarrRK. The prevalence of specific psychiatric disorders among homeless individuals in the inner city of Los Angeles. Arch Gen Psychiatry1988; 45:1085–92.
18.
RobertsonMJClarkRACharleboisEDTulskeyJLongHLBangsbergDR, HIV seroprevalence among homeless and marginally housed adults in San Francisco. Am J Public Health2004; 94:1207–17.
19.
RobertsonMJZlotnickCWesterfeltA.Drug use disorders and treatment contact among homeless adults in Alameda County, California. Am J Public Health1997; 87:221–8.
20.
SmithEMNorthCSSpitznagelEL. Are hard-to-interview street dwellers needed in assessing psychiatric disorders in homeless men?Int J Methods Psychiatr Res1991; 1:69–78.
21.
BurnamMAKoegelP.Methodology for obtaining a representative sample of homeless persons. The Los Angeles Skid Row Study. Eval Rev1988; 12:117–52.
22.
VernezGBurnamMAMcGlynnEATrudeSMattmanBS. Review of California's program for the homeless mentally disabled [R-3631-CDMH]. Santa Monica (CA): The RAND Corp.; 1988.
23.
RAND Survey Research Group. Downtown health project hepatitis study summary report. Santa Monica (CA): RAND Corp.; 2004.
24.
RobinsLCottlerLBucholzKComptonW.C-DIS-IV: Computerized diagnostic interview schedule, version IV. St. Louis: Washington University in St. Louis Department of Psychiatry; 2000.
25.
KralAHBluthenthalRNBoothREWattersJK. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am J Public Health1998; 88:108–13.
26.
Des JarlaisDCHagenHArastehKMcKnightCSemaanSPerlmanDC. Can intranasal drug use reduce HCV infection among injecting drug users?Drug Alcohol Depend2011; 119:201–6.
27.
AlterMJKuhnertWLFinelliL.Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Recomm Rep2003; 52(RR-3):1–13, 15.
28.
SAS Institute, Inc. SAS®: Version 6.12. Cary (NC): SAS Institute, Inc.; 1999.
29.
Stata Corp. Stata®: Release 5. College Station (TX): Stata Corp.; 1993.
30.
ChooQLKuoGWeinerAJOverbyLRBradleyDWHoughtonM.Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science1989; 244:359–62.
31.
KrawczynskiKAlterMJRobertsonBHLuLSpelbringJEMcCaustlandKA. Environmental stability of hepatitis C virus (HCV): Viability of dried/stored HCV in chimpanzee infectivity studies. Program and Abstracts of the 54th Annual Meeting of the American Society for the Study of Liver Disease. Philadelphia: W.B.Saunders; 2003.
32.
Centers for Disease Control and Prevention (US). HIV/AIDS basics: How well does HIV survive outside the body? [cited2009 Oct 22]. Available from: URL: http://www.cdc.gov/hiv/resources/qa/qa35.htm
33.
AlterMJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol2007; 13:2436–441.
ShepardCWFinelliLAlterMJ. Global epidemiology of hepatitis C virus infection. The Lancet2005; 5:558–67.
36.
RosenblumANuttbrockLMcQuistionHLMaguraSJosephH.Hepatitis C and substance use in a sample of homeless people in New York City. J Addict Dis2001; 20:15–25.
37.
WilliamsITBoazKOpenoKAventKBedellMGillJ, Incidence and risk factors for hepatitis C in the USA, 1982–2004: The role of injection drug use. J Clin Virol2006; 36:S44.
38.
Centers for Disease Control and Prevention (US). Hepatitis surveillance report #61. Department of Health and Human Services, Public Health Service (US); 2006.
39.
CookPAMcVeighJSyedQMuttonKBellisMA. Predictors of hepatitis B and C infection in injecting drug users both in and out of drug treatment. Addiction2001; 96:1787–97.
40.
ScheinmannRHaganHLelutiu-WeinbergerCSternRDes JarlaisDCFlomPL, Non-injection drug use and hepatitis C virus: A systematic review. Drug Alcohol Depend2007; 89:1–12.
41.
KoYCHoMsChiangTAChangSJChangPY. Tattooing as a risk of hepatitis C virus infection. J Med Virol1992; 38:288–91.
42.
HaleyRWFischerRP. Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine (Baltimore)2001; 80:134–51.
43.
HaleyRWFischerRP. The tattooing paradox. Arch Intern Med2003; 163:1095–8.
44.
NishiokaSAGyorkosTWJosephLColletJPMacLeanJD. Tattooing and risk for transfusion-transmitted diseases: The role of the type, number and design of the tattoos, and the conditions in which they were performed. Epidemiol Infect2002; 128:63–71.
45.
NishiokaSAGyorkosTWJosephLColletJPMacLeanJ.Tattooing and transfusion-transmitted diseases in Brazil: A hospital-based cross-sectional matched study. Eur J Epidemiol2003; 18:441–9.
SilvermanALSekhonJSSaginawSJWiedbraukDBalasubramaniamMGordonSC. Tattoo application is not associated with an increased risk for chronic viral hepatitis. Am J Gastroenterol2000; 95:1312–5.
48.
AlterMJ. Epidemiology of hepatitis C. Hepatology1997; 26(3 Suppl 1):62S–65S.
49.
DienstagJL. Acute viral hepatitis. In: LongoAMFauciASKasperDLHauserSLJamesonJLLoscalzoJ. Harrison's principles of internal medicine. Volumes 1 and 2. 18th ed.New York: McGraw-Hill; 2011. p. 2537–57.
50.
ThompsonVVRaglandKEHallCSMorganMBangsbergDR. Provider assessment of eligibility for hepatitis C treatment in HIV-infected homeless and marginally housed persons. AIDS2005; 19suppl 3:S208–14.
51.
NealeJ. Homelessness, drug use and hepatitis C: A complex problem explored within the context of social exclusion. Int J Drug Policy2008; 19:429–35.
52.
DennisML. Changing the conventional rules: Surveying homeless people in nonconventional locations. Housing Policy Debates1991; 2:701–32.
53.
BurtMRAronLYDouglasTValenteJLeeEIwenB.Homelessness: Programs and the people they serve—summary report. Washington: Urban Institute; 1999.
54.
BreakeyWRFischerPJKramerMNestadtGRomanoskiAJRossA, Health and mental health problems of homeless men and women in Baltimore. JAMA1989; 262:1352–7.
